0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-invasive Parenteral Screening Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-39C854
Home | Market Reports | Health| Nursing
Global Non invasive Parenteral Screening Market Insights and Forecast to 2028
BUY CHAPTERS

Global Non-invasive Parenteral Screening Market Research Report 2024

Code: QYRE-Auto-39C854
Report
January 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-invasive Parenteral Screening Market Size

The global Non-invasive Parenteral Screening market was valued at US$ 3812 million in 2023 and is anticipated to reach US$ 7241.6 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.

Non-invasive Parenteral Screening Market

Non-invasive Parenteral Screening Market

Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Non-invasive Parenteral Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Parenteral Screening.

Report Scope

The Non-invasive Parenteral Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-invasive Parenteral Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-invasive Parenteral Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Non-invasive Parenteral Screening Market Report

Report Metric Details
Report Name Non-invasive Parenteral Screening Market
Accounted market size in 2023 US$ 3812 million
Forecasted market size in 2030 US$ 7241.6 million
CAGR 9.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Instruments
  • Consumables
Segment by Application
  • Diagnostic Laboratories
  • Hospitals
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Non-invasive Parenteral Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-invasive Parenteral Screening Market growing?

Ans: The Non-invasive Parenteral Screening Market witnessing a CAGR of 9.6% during the forecast period 2024-2030.

What is the Non-invasive Parenteral Screening Market size in 2030?

Ans: The Non-invasive Parenteral Screening Market size in 2030 will be US$ 7241.6 million.

Who are the main players in the Non-invasive Parenteral Screening Market report?

Ans: The main players in the Non-invasive Parenteral Screening Market are GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group

What are the Application segmentation covered in the Non-invasive Parenteral Screening Market report?

Ans: The Applications covered in the Non-invasive Parenteral Screening Market report are Diagnostic Laboratories, Hospitals

What are the Type segmentation covered in the Non-invasive Parenteral Screening Market report?

Ans: The Types covered in the Non-invasive Parenteral Screening Market report are Instruments, Consumables

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive Parenteral Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Non-invasive Parenteral Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-invasive Parenteral Screening Market Perspective (2019-2030)
2.2 Non-invasive Parenteral Screening Growth Trends by Region
2.2.1 Global Non-invasive Parenteral Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Non-invasive Parenteral Screening Historic Market Size by Region (2019-2024)
2.2.3 Non-invasive Parenteral Screening Forecasted Market Size by Region (2025-2030)
2.3 Non-invasive Parenteral Screening Market Dynamics
2.3.1 Non-invasive Parenteral Screening Industry Trends
2.3.2 Non-invasive Parenteral Screening Market Drivers
2.3.3 Non-invasive Parenteral Screening Market Challenges
2.3.4 Non-invasive Parenteral Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-invasive Parenteral Screening Players by Revenue
3.1.1 Global Top Non-invasive Parenteral Screening Players by Revenue (2019-2024)
3.1.2 Global Non-invasive Parenteral Screening Revenue Market Share by Players (2019-2024)
3.2 Global Non-invasive Parenteral Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-invasive Parenteral Screening Revenue
3.4 Global Non-invasive Parenteral Screening Market Concentration Ratio
3.4.1 Global Non-invasive Parenteral Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Revenue in 2023
3.5 Non-invasive Parenteral Screening Key Players Head office and Area Served
3.6 Key Players Non-invasive Parenteral Screening Product Solution and Service
3.7 Date of Enter into Non-invasive Parenteral Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-invasive Parenteral Screening Breakdown Data by Type
4.1 Global Non-invasive Parenteral Screening Historic Market Size by Type (2019-2024)
4.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2025-2030)
5 Non-invasive Parenteral Screening Breakdown Data by Application
5.1 Global Non-invasive Parenteral Screening Historic Market Size by Application (2019-2024)
5.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Non-invasive Parenteral Screening Market Size (2019-2030)
6.2 North America Non-invasive Parenteral Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Non-invasive Parenteral Screening Market Size by Country (2019-2024)
6.4 North America Non-invasive Parenteral Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-invasive Parenteral Screening Market Size (2019-2030)
7.2 Europe Non-invasive Parenteral Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Non-invasive Parenteral Screening Market Size by Country (2019-2024)
7.4 Europe Non-invasive Parenteral Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-invasive Parenteral Screening Market Size (2019-2030)
8.2 Asia-Pacific Non-invasive Parenteral Screening Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-invasive Parenteral Screening Market Size (2019-2030)
9.2 Latin America Non-invasive Parenteral Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Non-invasive Parenteral Screening Market Size by Country (2019-2024)
9.4 Latin America Non-invasive Parenteral Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-invasive Parenteral Screening Market Size (2019-2030)
10.2 Middle East & Africa Non-invasive Parenteral Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Non-invasive Parenteral Screening Introduction
11.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Philips
11.2.1 Philips Company Detail
11.2.2 Philips Business Overview
11.2.3 Philips Non-invasive Parenteral Screening Introduction
11.2.4 Philips Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.2.5 Philips Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Non-invasive Parenteral Screening Introduction
11.3.4 Illumina Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.3.5 Illumina Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Introduction
11.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Non-invasive Parenteral Screening Introduction
11.5.4 Roche Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.5.5 Roche Recent Development
11.6 PacBio
11.6.1 PacBio Company Detail
11.6.2 PacBio Business Overview
11.6.3 PacBio Non-invasive Parenteral Screening Introduction
11.6.4 PacBio Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.6.5 PacBio Recent Development
11.7 Perkinelmer
11.7.1 Perkinelmer Company Detail
11.7.2 Perkinelmer Business Overview
11.7.3 Perkinelmer Non-invasive Parenteral Screening Introduction
11.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.7.5 Perkinelmer Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Detail
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Non-invasive Parenteral Screening Introduction
11.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.8.5 Qiagen Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Non-invasive Parenteral Screening Introduction
11.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.9.5 Agilent Technologies Recent Development
11.10 BGI Group
11.10.1 BGI Group Company Detail
11.10.2 BGI Group Business Overview
11.10.3 BGI Group Non-invasive Parenteral Screening Introduction
11.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Business (2019-2024)
11.10.5 BGI Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Non-invasive Parenteral Screening Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Instruments
    Table 3. Key Players of Consumables
    Table 4. Global Non-invasive Parenteral Screening Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Non-invasive Parenteral Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Non-invasive Parenteral Screening Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Non-invasive Parenteral Screening Market Share by Region (2019-2024)
    Table 8. Global Non-invasive Parenteral Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Non-invasive Parenteral Screening Market Share by Region (2025-2030)
    Table 10. Non-invasive Parenteral Screening Market Trends
    Table 11. Non-invasive Parenteral Screening Market Drivers
    Table 12. Non-invasive Parenteral Screening Market Challenges
    Table 13. Non-invasive Parenteral Screening Market Restraints
    Table 14. Global Non-invasive Parenteral Screening Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Non-invasive Parenteral Screening Market Share by Players (2019-2024)
    Table 16. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening as of 2023)
    Table 17. Ranking of Global Top Non-invasive Parenteral Screening Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Non-invasive Parenteral Screening Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Non-invasive Parenteral Screening Product Solution and Service
    Table 21. Date of Enter into Non-invasive Parenteral Screening Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Non-invasive Parenteral Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2019-2024)
    Table 25. Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2025-2030)
    Table 27. Global Non-invasive Parenteral Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Non-invasive Parenteral Screening Revenue Market Share by Application (2019-2024)
    Table 29. Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Non-invasive Parenteral Screening Revenue Market Share by Application (2025-2030)
    Table 31. North America Non-invasive Parenteral Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Non-invasive Parenteral Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Non-invasive Parenteral Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Non-invasive Parenteral Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Non-invasive Parenteral Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Non-invasive Parenteral Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Non-invasive Parenteral Screening Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Non-invasive Parenteral Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Non-invasive Parenteral Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Non-invasive Parenteral Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Non-invasive Parenteral Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 46. GE Healthcare Company Detail
    Table 47. GE Healthcare Business Overview
    Table 48. GE Healthcare Non-invasive Parenteral Screening Product
    Table 49. GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 50. GE Healthcare Recent Development
    Table 51. Philips Company Detail
    Table 52. Philips Business Overview
    Table 53. Philips Non-invasive Parenteral Screening Product
    Table 54. Philips Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 55. Philips Recent Development
    Table 56. Illumina Company Detail
    Table 57. Illumina Business Overview
    Table 58. Illumina Non-invasive Parenteral Screening Product
    Table 59. Illumina Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 60. Illumina Recent Development
    Table 61. Thermo Fisher Scientific Company Detail
    Table 62. Thermo Fisher Scientific Business Overview
    Table 63. Thermo Fisher Scientific Non-invasive Parenteral Screening Product
    Table 64. Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 65. Thermo Fisher Scientific Recent Development
    Table 66. Roche Company Detail
    Table 67. Roche Business Overview
    Table 68. Roche Non-invasive Parenteral Screening Product
    Table 69. Roche Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 70. Roche Recent Development
    Table 71. PacBio Company Detail
    Table 72. PacBio Business Overview
    Table 73. PacBio Non-invasive Parenteral Screening Product
    Table 74. PacBio Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 75. PacBio Recent Development
    Table 76. Perkinelmer Company Detail
    Table 77. Perkinelmer Business Overview
    Table 78. Perkinelmer Non-invasive Parenteral Screening Product
    Table 79. Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 80. Perkinelmer Recent Development
    Table 81. Qiagen Company Detail
    Table 82. Qiagen Business Overview
    Table 83. Qiagen Non-invasive Parenteral Screening Product
    Table 84. Qiagen Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 85. Qiagen Recent Development
    Table 86. Agilent Technologies Company Detail
    Table 87. Agilent Technologies Business Overview
    Table 88. Agilent Technologies Non-invasive Parenteral Screening Product
    Table 89. Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 90. Agilent Technologies Recent Development
    Table 91. BGI Group Company Detail
    Table 92. BGI Group Business Overview
    Table 93. BGI Group Non-invasive Parenteral Screening Product
    Table 94. BGI Group Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)
    Table 95. BGI Group Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-invasive Parenteral Screening Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Non-invasive Parenteral Screening Market Share by Type: 2023 VS 2030
    Figure 3. Instruments Features
    Figure 4. Consumables Features
    Figure 5. Global Non-invasive Parenteral Screening Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Non-invasive Parenteral Screening Market Share by Application: 2023 VS 2030
    Figure 7. Diagnostic Laboratories Case Studies
    Figure 8. Hospitals Case Studies
    Figure 9. Non-invasive Parenteral Screening Report Years Considered
    Figure 10. Global Non-invasive Parenteral Screening Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Non-invasive Parenteral Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Non-invasive Parenteral Screening Market Share by Region: 2023 VS 2030
    Figure 13. Global Non-invasive Parenteral Screening Market Share by Players in 2023
    Figure 14. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Non-invasive Parenteral Screening Revenue in 2023
    Figure 16. North America Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Non-invasive Parenteral Screening Market Share by Country (2019-2030)
    Figure 18. United States Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. Canada Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Europe Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Non-invasive Parenteral Screening Market Share by Country (2019-2030)
    Figure 22. Germany Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. France Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. U.K. Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Italy Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Russia Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Nordic Countries Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Asia-Pacific Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Non-invasive Parenteral Screening Market Share by Region (2019-2030)
    Figure 30. China Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Japan Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. South Korea Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Southeast Asia Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. India Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Australia Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Latin America Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Non-invasive Parenteral Screening Market Share by Country (2019-2030)
    Figure 38. Mexico Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Brazil Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Non-invasive Parenteral Screening Market Share by Country (2019-2030)
    Figure 42. Turkey Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Saudi Arabia Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 45. Philips Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 46. Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 48. Roche Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 49. PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 50. Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 51. Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 52. Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 53. BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS